is pioglitazone a glp-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? The GLP-1 revolution: What UAB
Description
Cheng HW, Yang SF, Liao PL, Lee CH, Jong GP
Subsequently, the drug has been approved across the European Union (September 2022), Canada (November 2022), and Australia (December 2022)
Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM
Thirst can arise through several pathways when taking Ozempic: it may reflect dehydration secondary to gastrointestinal side effects such as nausea, vomiting, or diarrhoeacommon reactions, particularly during dose titration
The study by Tao et al
